Zobrazeno 1 - 10
of 104
pro vyhledávání: '"M. Coustans"'
Autor:
M. Michel, E. Le Page, D.A. Laplaud, R. Wardi, C. Lebrun, F. Zagnoli, S. Wiertlewski, M. Coustans, G. Edan, K. Chevreul, D. Veillard, F. Lallement, M. Cohen, C. Blanchard, E. Sartori, O. Demarco, F. Rouhart, C. Papeix, G. Taurin, T. Anani, P. Kassiotis, C. Hamon, M.A. Lester, M. Merienne
Publikováno v:
Revue Neurologique
Revue Neurologique, 2022, 178 (3), pp.241-248. ⟨10.1016/j.neurol.2021.06.009⟩
Revue Neurologique, Elsevier Masson, 2021, ⟨10.1016/j.neurol.2021.06.009⟩
Revue Neurologique, 2022, 178 (3), pp.241-248. ⟨10.1016/j.neurol.2021.06.009⟩
Revue Neurologique, Elsevier Masson, 2021, ⟨10.1016/j.neurol.2021.06.009⟩
International audience; Background: Studies have shown that oral high-dose methylprednisolone (MP) is non-inferior to intravenous MP in treating multiple sclerosis relapses in terms of effectiveness and tolerance. In order to assist with resource all
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e5e81c07d2510bf92993c34f99a5caa
https://univ-rennes.hal.science/hal-03414558
https://univ-rennes.hal.science/hal-03414558
Autor:
C. Donzé, C. Papeix, C. Lebrun-Frenay, C. Lebrun-Frénay, N. Collongues, M. de Seze, A. Dinh, A. Even, C. Scheiber-Nogueira, C. Bensa, B. Bourre, C. Carra-Dallière, J. Ciron, M. Cohen, A.M. Guennoc, C. Louapre, F. Lebreton, L. Michel, E. Maillart, B. Audoin, X. Ayrignac, P. Bernady, B. Brochet, P. Clavelou, R. Colamarino, A. Declemy, J. de Seze, N. Derache, J.-M. Faucheux, O. Heinzlef, P. Labauge, D. Laplaud, E. Lepage, E. Leray, L. Magy, G. Mathey, C. Mekies, V. Mondain, E. Planque, J. Pelletier, S. Pittion, B. Stankhof, P. Tournaire, E. Thouvenot, S. Vukusic, S. Wiertlevski, H. Zephir, H. Alchaar, G. Androdias, M. Benazet, D. Bensmail, D. Biotti, A. Blanchard-Dauphin, M. Bonnan, C. Boutière, P. Branger, S. Bresch, J.-P. Bru, J.-P. Camdessanché, E. Castel Canal, M. Coustans, O. Casez, B. Castan, A. Creange, E. Creisson, T. De Broucker, R. Depaz, X. Douay, C. Dulau, F. Durand-Dubief, O. Fagniez, M. Faucher, A. Floch, M. Fournier, A. Fromont, P. Gallien, X. Gamé, D. Gault, A. Gayou, M. Giroux, O. Gout, J. Grimaud, P. Hautecoeur, A. Kerbrat, L. Kremer, A. Kwiatkowski, C. Labeyrie, S. Lachaud, C. Lanctin-Garcia, L. Lanotte, E. Manchon, A. Maurousset, A.-M. Milor, X. Moisset, A. Mont-Cuquet, T. Moreau, J.-C. Ouallet, I. Patry, D. Peaureaux, M.-C. Pouget, V. Pourcher Martinez, C. Radot, A. Ruet, C. Saint-Val, A. Salmon, F. Taithe, P. Tatevin, M. Vaillant, J.-P. Stahl, F. Vuoto, C. Zaenker
Publikováno v:
Revue Neurologique
Revue Neurologique, 2020, 176 (10), pp.804-822. ⟨10.1016/j.neurol.2020.02.011⟩
Revue Neurologique, Elsevier Masson, 2020, 176 (10), pp.804-822. ⟨10.1016/j.neurol.2020.02.011⟩
Revue Neurologique, 2020, 176 (10), pp.804-822. ⟨10.1016/j.neurol.2020.02.011⟩
Revue Neurologique, Elsevier Masson, 2020, 176 (10), pp.804-822. ⟨10.1016/j.neurol.2020.02.011⟩
Objectives Establish recommendations for the management of UTIs in MS patients. Background Urinary tract infections (UTIs) are common during multiple sclerosis (MS) and are one of the most common comorbidities potentially responsible for deaths from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a5dfd3e0390728753246cc4048803eb
https://hal.umontpellier.fr/hal-03339824
https://hal.umontpellier.fr/hal-03339824
Autor:
C. Lebrun, S. Vukusic, V. Abadie, C. Achour, F. Ader, H. Alchaar, A. Alkhedr, F. Andreux, G. Androdias, R. Arjmand, B. Audoin, D. Audry, D. Aufauvre, C. Autreaux, X. Ayrignac, M. Bailbe, M. Benazet, C. Bensa, D. Bensmail, E. Berger, P. Bernady, Y. Bertagna, D. Biotti, A. Blanchard-Dauphin, J. Bonenfant, M. Bonnan, B. Bonnemain, F. Borgel, E. Botelho-Nevers, S. Boucly, B. Bourre, C. Boutière, P. Branger, D. Brassat, S. Bresch, V. Breuil, B. Brochet, H. Brugeilles, P. Bugnon, P. Cabre, J.-P. Camdessanché, C. Carra-Dalière, O. Casez, J.-M. Chamouard, B. Chassande, P. Chataignier, M. Chbicheb, A. Chenet, J. Ciron, P. Clavelou, M. Cohen, R. Colamarino, N. Collongues, I. Coman, P.-R. Corail, S. Courtois, M. Coustans, A. Creange, E. Creisson, N. Daluzeau, C. Davenas, J. De Seze, M. Debouverie, R. Depaz, N. Derache, L. Divio, X. Douay, C. Dulau, F. Durand-Dubief, G. Edan, Z. Elias, O. Fagniez, M. Faucher, J.-M. Faucheux, M. Fournier, A. Gagneux-Brunon, P. Gaida, P. Galli, P. Gallien, J. Gaudelus, D. Gault, A. Gayou, M. Genevray, A. Gentil, J. Gere, L. Gignoux, M. Giroux, P. Givron, O. Gout, J. Grimaud, A.-M. Guennoc, N. Hadhoum, P. Hautecoeur, O. Heinzlef, M. Jaeger, S. Jeannin, L. Kremer, A. Kwiatkowski, P. Labauge, C. Labeyrie, S. Lachaud, I. Laffont, C. Lanctin-Garcia, J. Lannoy, L. Lanotte, D. Laplaud, D. Latombe, M. Lauxerois, E. Le Page, C. Lebrun-Frenay, P. Lejeune, P. Lejoyeux, B. Lemonnier, E. Leray, C.-M. Loche, C. Louapre, C. Lubetzki, A. Maarouf, B. Mada, L. Magy, E. Maillart, E. Manchon, R. Marignier, P. Marque, G. Mathey, A. Maurousset, C. Mekies, M. Merienne, L. Michel, A.-M. Milor, X. Moisset, A. Montcuquet, T. Moreau, N. Morel, M. Moussa, J.-P. Naudillon, M. Normand, P. Olive, J.-C. Ouallet, O. Outteryck, C. Pacault, C. Papeix, I. Patry, D. Peaureaux, J. Pelletier, B. Pichon, S. Pittion, E. Planque, M.-C. Pouget, V. Pourcher, C. Radot, I. Robert, F. Rocher, A. Ruet, C. Saint-Val, J.-Y. Salle, A. Salmon, E. Sartori, S. Schaeffer, B. Stankhof, F. Taithe, E. Thouvenot, C. Tizon, A. Tourbah, P. Tourniaire, M. Vaillant, P. Vermersch, S. Vidil, A. Wahab, M.-H. Warter, S. Wiertlewski, B. Wiplosz, B. Wittwer, C. Zaenker, H. Zephir
Publikováno v:
Revue Neurologique
Revue Neurologique, Elsevier Masson, 2019, 175 (6), pp.341-357. ⟨10.1016/j.neurol.2019.04.001⟩
Revue Neurologique, 2019, 175 (6), pp.341-357. ⟨10.1016/j.neurol.2019.04.001⟩
Revue Neurologique, Elsevier Masson, 2019, 175 (6), pp.341-357. ⟨10.1016/j.neurol.2019.04.001⟩
Revue Neurologique, 2019, 175 (6), pp.341-357. ⟨10.1016/j.neurol.2019.04.001⟩
Objectives To establish recommendations on immunization for patients with multiple sclerosis (MS). Background Vaccines have been suspected in the past to trigger MS and relapses. With the extension of the immunoactive treatment arsenal, other concern
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4224df57b3ca0c4e2cc01130cb05e47
https://hal.ehesp.fr/hal-02546158
https://hal.ehesp.fr/hal-02546158
Autor:
Caroline Lavie, Fabien Rollot, Françoise Durand-Dubief, Romain Marignier, Iuliana Ionescu, Romain Casey, Thibault Moreau, Patricia Tourniaire, Michael Hutchinson, Marie Béatrice D’Hooghe, David-Axel Laplaud, Pierre Clavelou, Jérôme De Sèze, Marc Debouverie, David Brassat, Jean Pelletier, Christine Lebrun-Frenay, Emmanuelle Le Page, Giovanni Castelnovo, Eric Berger, Patrick Hautecoeur, Olivier Heinzlef, Luca Durelli, Marinella Clerico, Maria Trojano, Francesco Patti, Sandra Vukusic, A. Alpérovitch, H. Carton, M.B. d’Hooghe, O. Hommes, M. Hutchinson, P. Adeleine, A. Biron, P. Cortinovis-Tourniaire, J. Grimaud, M. Hours, T. Moreau, S. Vukusic, C. Confavreux, G. Chauplannaz, D. Latombe, M. Clanet, G. Lau, L. Rumbach, J.Y. Goas, F. Rouhart, A. Mazingue, E. Roullet, M. Madigand, P. Hautecoeur, P. Brunet, G. Edan, C. Allaire, G. Riffault, J. Leche, T. Benoit, C. Simonin, F. Ziegler, J.C. Baron, Y. Rivrain, R. Dumas, D. Loche, J.C. Bourrin, B. Huttin, B. Delisse, I. Gibert, C. Boulay, M. Verceletto, G. Durand, G. Bonneviot, R. Gil, M.A. Hedreville, C. Belair, R.J. Poitevin, J.L. Devoize, P. Wyremblewski, F. Delestre, A. Setiey, G. Comi, M. Filippi, A. Ghezzi, V. Martinelli, P. Rossi, M. Zaffaroni, M.R. Tola, M.P. Amato, C. Fioretti, G. Meucci, M. Inglese, G.L. Mancardi, D. Gambi, A. Thomas, M. Cavazzuti, A. Citterio, A. Heltberg, H.J. Hansen, O. Fernandez, F. Romero, T. Arbizu, J.J. Hernandez, C. De Andres de Frutos, D. Geffner Sclarky, Y. Aladro Benito, P. Reyes Yanes, M Aguilar, J.A. Burguera, R. Yaya, W. Bonakim Dib, D. Arzua-Mouronte, C.J.M. Sindic, R. Medaer, H. Roose, K.M.J. Geens, D. Guillaume, M. Van Zandycke, J. Janssens, M. Cornette, L. Mol, F. Weilbach, P. Flachenecker, H.P. Hartung, J. Haas, I. Tendolkar, E. Sindrn, H.W. Kölmel, D. Reichel, M. Rauch, S. Preuss, S. Poser, E. Mauch, S. Strausser-Fuchs, H. Kolleger, S. Hawkins, S.J.L. Howell, J.E. Rees, A. Thompson, M. Johnson, M. Boggild, R.P. Gregory, D. Bates, I. Bone, C. Polman, S. Frequin, P. Jongen, J. Correia de Sa, M.E. Rio, S. Huber, J. Lechner-Scott, L. Kappos, I. Ionescu, C. Cornu, M. El-Etr, E.E. Baulieu, M Schumacher, D.H. Miller, M. Pugeat, C. d’Archangues, J. Conard, J. Ménard, R. Sitruk-Ware, C. Pelissier, S. Dat, J. Belaïsch-Allard, N. Athéa, D. Büschsenschutz, O. Lyon-Caen, R. Gonsette, J.P. Boissel, P. Ffrench, F. Durand-Dubief, F. Cotton, C. Pachai, L. Bracoud, G. Androdias, R. Marignier, D.A. Laplaud, S. Wiertlewski, C. Lanctin-Garcia, G. Couvreur, G. Madinier, P. Clavelou, F. Taithe, D. Aufauvre, N. Guy, A. Ferrier, J. De Sèze, N. Collongues, M. Debouverie, F. Viala, D. Brassat, A. Gerdelat-Mas, P. Henry, J. Pelletier, A. Rico-Lamy, C. Lebrun-Frenay, E. Lepage, V. Deburghraeve, G. Castelnovo, E. Berger, M. Blondiau, O. Heinzlef, M. Coustans, C. Clerc, L. Rieu, M. Lauxerois, G. Hinzelin, J.C. Ouallet, D. Minier, P. Vion, N. Gromaire-Fayolle, N. Derache, E. Thouvenot, M. Sallansonnet-Froment, P. Tourniaire, L. Toureille, F. Borgel, B. Stankoff, C. Moroianu, A.M. Guennoc, C.L. Tournier-Gervason, S. Peysson, M. Trojano, F. Patti, E. D’Amico, L. Motti, L. Durelli, A. Tavella
Publikováno v:
Multiple Sclerosis Journal
Multiple Sclerosis Journal, SAGE Publications, 2019, 25 (4), pp.591-600. ⟨10.1177/1352458518763080⟩
Multiple Sclerosis Journal, 2019, 25 (4), pp.591-600. ⟨10.1177/1352458518763080⟩
Multiple Sclerosis Journal, SAGE Publications, 2019, 25 (4), pp.591-600. ⟨10.1177/1352458518763080⟩
Multiple Sclerosis Journal, 2019, 25 (4), pp.591-600. ⟨10.1177/1352458518763080⟩
Background: Obstetrical analgesia remains a matter of controversy because of the fear of neurotoxicity of local anesthetics on demyelinated fibers or their potential relationship with subsequent relapses. Objective: To assess the impact of neuraxial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f28f65ab3be4a062efa806379b5d0184
https://hal.univ-lorraine.fr/hal-02158735
https://hal.univ-lorraine.fr/hal-02158735
Autor:
Sandrine Wiertlewski, Christine Lebrun, M. Coustans, Pierre Labauge, Gilles Edan, Société Francophone de la Sclérose en Plaques, Pascal Derkinderen, Mikael Cohen, C Carra-Dallieres, Patrick Devos, F Lefrere, B Daumas-Duport, Patrick Vermersch, Hélène Zéphir, Eric Berger, Jean Pelletier, C Brosset, E Auffray-Calvier, Lucien Rumbach, P. Lejeune, Romain Deschamps, Emeline Duhin, J-B N'Kendjuo, David-Axel Laplaud, G Balloy, Olivier Gout, Laure Michel, L Suchet, E. Le Page, J. de Seze
Publikováno v:
Journal of Neurology
Journal of Neurology, Springer Verlag, 2018, 265 (10), pp.2251-2259. ⟨10.1007/s00415-018-8984-7⟩
Journal of Neurology, 2018, 265 (10), pp.2251-2259. ⟨10.1007/s00415-018-8984-7⟩
Journal of Neurology, Springer Verlag, 2018, 265 (10), pp.2251-2259. ⟨10.1007/s00415-018-8984-7⟩
Journal of Neurology, 2018, 265 (10), pp.2251-2259. ⟨10.1007/s00415-018-8984-7⟩
Tumefactive demyelinating lesions of the central nervous system can be the initial presentation in various pathological entities [multiple sclerosis (the most common), Balo’s concentric sclerosis, Schilder’s disease and acute disseminated encepha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::007b19cf83d70f3b8d84a3399fab04fe
https://hal.archives-ouvertes.fr/hal-02066038
https://hal.archives-ouvertes.fr/hal-02066038
Publikováno v:
Multiple Sclerosis Journal
Multiple Sclerosis Journal, SAGE Publications, 2013, 19 (4), pp.458-65. ⟨10.1177/1352458512456613⟩
Multiple Sclerosis Journal, 2013, 19 (4), pp.458-65. ⟨10.1177/1352458512456613⟩
Multiple Sclerosis Journal, SAGE Publications, 2013, 19 (4), pp.458-65. ⟨10.1177/1352458512456613⟩
Multiple Sclerosis Journal, 2013, 19 (4), pp.458-65. ⟨10.1177/1352458512456613⟩
Background: Benign multiple sclerosis (BMS) is a controversial concept which is still debated. However identification of this kind of patients is crucial to prevent them from unnecessary exposure to aggressive and/or long term medical treatments. Obj
Publikováno v:
Revue Neurologique. 173:S123-S124
Introduction ACCEPT est un auto-questionnaire valide mesurant l’acceptance des patients pour leur traitement. L’acceptance est definie comme la balance entre avantages et inconvenients d’un traitement, evaluee par le patient lui-meme. Objectifs
Autor:
François Lallement, F. Rouhart, Gilles Edan, M. Coustans, David Laplaud, E. Sartori, Emmanuelle Leray, Anne Kerbrat, C. Guiziou, C. Desormeaux, R. Wardi, P. Kassiotis, E. Le Page, P. Diraison, Sandrine Wiertlewski, T. Anani
Publikováno v:
Journal of the Neurological Sciences
Journal of the Neurological Sciences, 2011, 308 (1-2), pp.98--102. ⟨10.1016/j.jns.2011.05.043⟩
Journal of the Neurological Sciences, Elsevier, 2011, 308 (1-2), pp.98--102. ⟨10.1016/j.jns.2011.05.043⟩
Journal of the Neurological Sciences, 2011, 308 (1-2), pp.98--102. ⟨10.1016/j.jns.2011.05.043⟩
Journal of the Neurological Sciences, Elsevier, 2011, 308 (1-2), pp.98--102. ⟨10.1016/j.jns.2011.05.043⟩
International audience; BACKGROUND: In order to reduce the risk of progressive multifocal leucoencephalopathy when using natalizumab for more than 12 months, a 6-month drug holiday has been discussed. However, the consequences on short term disease a
Autor:
Gilles Edan, J. Yaouanq, David Laplaud, M. Coustans, Emmanuelle Le Page, Emmanuelle Leray, Joel Oger
Publikováno v:
Brain
It is well documented that disability accumulation in multiple sclerosis is correlated with axonal injury and that the extent of axonal injury is correlated with the degree of inflammation. However, the interdependence between focal inflammation, dif
Publikováno v:
Revue Neurologique. 162:185-194
Resume Introduction Nous rapportons une etude observationnelle de 100 patients consecutifs ayant une SEP remittente agressive, traites par mitoxantrone (MITOX) selon les criteres de l’AMM obtenue en octobre 2003 (ELSEP ® ). Methode Cent patients a